Clinical trial Recruiting at 1 site Observational Ages 18 and up

Lipid and mitochondrial clues in aortic aneurysm with bicuspid or tricuspid valves

Official title: A Prospective, Single-center, Open-label Study of Lipid Metabolism and Mitochondrial Function in Myeloid Cells and Total Aortic Tissue in Patients With Ascending Thoracic Aortic Aneurysm (ATA) and Bicuspid (BA) or Tricuspid (TA) Aortic Valves.

Run by Centre Hospitalier Universitaire Dijon · NCT07695545 · Data updated 2026-11-12

This study tests whether inflammatory and metabolic signatures in myeloid cells and aortic tissue differ between patients with bicuspid versus tricuspid aortic valves who need surgery for ascending aortic aneurysm.

More Ascending Aortic Aneurysm trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorCentre Hospitalier Universitaire Dijon
Academic / other
Locations1 site (Dijon)
StatusRecruiting
StartedJune 28, 2026
Main results expectedAugust 2029
Study endsAugust 2029
Registry record updatedJuly 13, 2026
Trial IDNCT07695545 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with ascending aortic aneurysm who are scheduled for surgical repair and have a preoperative confirmation of bicuspid or tricuspid aortic valve.

Probably not a fit

Patients who do not have the specified valve morphology, or whose surgery is not performed, may not receive insights from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an observational study comparing molecular patterns in blood-derived myeloid cells and discarded ascending aortic tissue from patients undergoing surgical repair for ascending aortic aneurysm. The researchers will analyze inflammatory, metabolic, and transcriptomic signatures to identify differences related to valve morphology (bicuspid vs. tricuspid). By collecting additional blood samples and tissue, the study aims to reveal potential biomarkers and targets for therapy related to aneurysm progression. Eligibility focuses on adults planning surgery and confirmed valve architecture, with several exclusions to ensure safety and data quality. No interventional treatments are tested in this design; findings would inform future research and clinical understanding.

Why it matters

Potential benefit: If successful, the study could identify biomarkers or molecular targets that help predict aneurysm progression or inform personalized treatment strategies.

How similar studies have gone: Previous research has shown that valve morphology and inflammatory/metabolic pathways can influence aneurysm biology, supporting the rationale for this comparative approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals who have given their consent
* Patients with an ascending aortic aneurysm for which surgical replacement is indicated
* Age \> 18 years
* Scheduled surgery
* Preoperative ultrasound confirmation of the heart valve architecture (bicuspid or tricuspid valve)

Exclusion Criteria:

* A person subject to a legal protective measure (guardianship, conservatorship)
* A person subject to a judicial safeguard measure - A pregnant woman, a woman in labor, or a breastfeeding woman
* Adults who are legally incapacitated or unable to give consent
* Emergency surgical procedures
* Patients with uncontrolled inflammatory or autoimmune conditions
* Patients with a history of recent acute infection (within the last 3 months or still undergoing treatment)
* Patients with a condition requiring immunosuppressants - Patients with a confirmed or suspected genetic aneurysm (Marfan syndrome, Loeys-Dietz syndrome, Ehlers-Danlos syndrome, etc.)
* Patients with a history of cardiac surgery

Where it's running

  • Chu Dijon Bourgogne
    Dijon, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.